Doctor Kameneva MV

McGowan Institute for Regenerative Medicine faculty member Marina Kameneva, PhD, Research Professor of Surgery at the University of Pittsburgh School of Medicine, Professor of Bioengineering, University of Pittsburgh, and Director of the Artificial Blood Program at the McGowan Institute, along with co-inventors Denis Bragin, PhD, and Edwin Nemoto, PhD, from the University of New Mexico, recently received a U.S. patent for their development entitled “Rheological treatment of brain ischemia by drag reducing polymers.”

From the patent summary:  The present disclosure provides methods and compositions for the treatment of acute or chronic cerebral ischemia by targeting the very basis of ischemia by improving the rheology of blood flow through arteries and capillaries and as such would be relevant in the treatment, amelioration, or prevention of acute and chronic ischemic conditions of various etiologies. According to a first embodiment, the present disclosure provides linear, blood soluble, non-toxic macromolecules, referred to herein as drag-reducing polymers (DRPs) for the treatment, amelioration, or prevention of brain (and other organs) ischemia and other conditions or injuries causing or potentially leading to ischemic injury. According to a second embodiment, the present disclosure provides a method for treating, ameliorating, or preventing brain (and other organs) ischemia of varying etiologies by the administration of DRP to a subject.

Read more…

U.S. Patent and Trademark Office Patent No. 9,763,975